PYY and diabetes mellitus: Enhancing endogenous PYY activity or using pharmacological agents that mimic PYY signaling may, therefore, represent a promising therapeutic strategy by stabilizing postprandial glucose levels—a primary objective in diabetes care, especially for individuals at elevated cardiovascular risk [63].